Hameln, Germany
Nantong, China
Siegfried offers more integrated capability in 2015 with new facilities in both Western and Eastern hemispheres. HAMELN, GERMANY Founded in 1950; a Siegfried company since December 2014; site awarded “Facility of the Year” in 2009. Site Scope – Development and Scale up of Sterile Forms – Clinical Manufacturing – Commercial Manufacturing and Packaging Site Capabilities – Vials (from 2 to 100 mL) – Ampoules (from 1 to 30 mL) – 8 flling lines – 2 product autoclaves – Automatic and semiautomatic visual inspection machines – Crack detection machines – Automatic labeling and packaging equipment Main Regulatory Certifcations EMA, FDA, Japan, ANVISA, MFDS S. Korea, Turkey
NANTONG, CHINA Founded 2014 with doors open in 2015; Siegfried Nantong offers complete life cycle management of API’s before, after and throughout patent protection phase(s). Site Scope – Development – Pilot & Launch – Commercial Manufacturing Site Capabilities – Hydrogenation up to 40 bar – Temperature range from minus 100 °C – 250 °C – Handling of hazardous materials – Chlorination & Bromination – Reactor sizes from 0.1 – 10 m3 – Total reactor capacity of 350 m3 Offers full-fedged compliancy FDA; EMA and SFDA (thermal oxidizer, waste treatment plant)
Siegfried has worldwide presence with chemical manufacturing multi-purpose cGMP sites located in: Zofngen, Switzerland; Pennsville, New Jersey (USA) and Nantong (China), and drug product manufacturing sites in Zofngen, Switzerland (Pilot), Malta, Irvine (USA) and Hameln (Germany).
www.siegfried.ch
